Navigation Links
Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
Date:5/23/2012

WEST ORANGE, N.J., May 23, 2012 /PRNewswire/ -- Everett Laboratories, Inc., Women's Health Care company, leader in the field of prenatal supplementation, today announced that it had filed a patent infringement lawsuit with a motion for a preliminary injunction in the United States District Court of New Jersey against Trigen Laboratories, Inc., a specialty niche pharmaceutical company.  The lawsuit asserts, among other things, that Trigen is infringing United States Patent No. 8,183,227 covering Everett's Vitafol®-One product, and seeks to prevent Trigen from making, selling, distributing and falsely branding its infringing, copycat products.  Everett's lawsuit alleges that it will be irreparably harmed unless the court issues a preliminary injunction that requires Trigen immediately to withdraw its patent-infringing products from the market.    

"We are fully committed to our innovation and to providing physicians and their patients with quality products for prenatal supplementation," said Lucas Sigman, Everett's Chief Executive Officer.  "Our prenatal supplementation portfolio represents one of the Company's most valuable assets, and provides significant market and competitive advantages.  We will not tolerate infringement of our patents, and we will do what is necessary to protect our proprietary rights."

Everett's lawsuit also alleges that Trigen's copycat products contain fish oil while Everett DHA is made from Algae oil.  "We are committed to providing pregnant women with the highest-quality prenatal supplementation.  That is our number one priority," said Louis Bongiovanni, Everett's Vice President of Sales. 

About Everett Laboratories, Inc.

Everett Laboratories is a New Jersey-based women's healthcare pharmaceutical company that has been providing essential pharmaceutical and nutritional products for four decades.  Everett is a subsidiary of The Chemo Group, a global healthcare corporation based in Spain with a presence in more than 30 countries.  The company recently licensed products for stress urinary incontinence, fertility, and the Stuart Natal line of pre-natal vitamins.  Everett is dedicated to providing advanced treatments and innovative new products to address unmet needs for women and families and to improving women's health.  The company strives to produce and market unique, first-in-class prescription and over the counter medications.


'/>"/>
SOURCE Everett Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Colonel (Ret) Everett McAllister Named as New PTCB Executive Director and Chief Executive Officer
2. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
3. The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc.
4. Unity Management Group Receives Large Purchase Order for their AIM Instrumentation Package From Barr Laboratories, Subdivision of TEVA Pharmaceuticals (NASDAQ: TEVA)
5. Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc.
6. MO BIO Laboratories, Inc. Launches the PowerWater® Sterivex™ DNA Isolation Kit
7. ICAP Ocean Tomo Announces Auction of Patch Based Drug Delivery and Monitoring Techniques from Entrega Laboratories, LLC
8. Announcement - Clontech Laboratories, Inc. Releases the Tet-Express™ Inducible Expression System
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2011
10. Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities
11. Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... DIEGO , Feb. 11, 2016 ... groundbreaking cell-isolation method that opens the door to ... until now have been impossible to isolate with ... to isolate specific tumor types in various stages ... genetic variants of these cells that are clinically ...
(Date:2/11/2016)... Conn. , Feb. 11, 2016  NanoViricides, ... that it has entered into an agreement with ... its nanoviricides® drug candidates in standard animal models ... Romanowski , Research Director. Dr. Romanowski has extensive ... discovery. --> Eric Romanowski , ...
(Date:2/11/2016)... -- North America , Europe ... global market is expected to reach USD 20,190.1 Million by 2020 ... 10.2%. --> North America , ... The global market is expected to reach USD 20,190.1 Million by ... of 10.2%. --> According to a new market research ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that ... Bank of Eastern Michigan last Friday in order to aid in the Flint water ... to include a facility located in Clio, only 15 miles away from Flint. , ...
(Date:2/10/2016)... California (PRWEB) , ... February 10, 2016 , ... ... are working together to expand dental health services to the developmentally disabled in ... We Care Dental’s operations to a new facility at 71-949 Highway 111, Suite ...
(Date:2/10/2016)... Middletown, PA (PRWEB) , ... February 10, 2016 , ... ... to offer two webinars in February 2016. Each webinar features a dynamic expert ... therapy to benefit their athletes, patients and facilities. Both events are free to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intermedix announced ... Emergency Medicine , an emergency medicine professional association, to support the organization's newly ... The American Academy of Emergency Medicine, or AAEM, seeks to empower emergency physicians ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... of a master charity program created to assist the local community. Pledging to ... community leaders and nonprofit organizations in the area. Their goal is to bring ...
Breaking Medicine News(10 mins):